An approach to estimating the environmental burden of cancer from known and probable carcinogens: application to Ontario, Canada.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
26 Jun 2020
Historique:
received: 25 02 2019
accepted: 24 04 2020
entrez: 28 6 2020
pubmed: 28 6 2020
medline: 11 11 2020
Statut: epublish

Résumé

Quantifying the potential cancer cases associated with environmental carcinogen exposure can help inform efforts to improve population health. This study developed an approach to estimate the environmental burden of cancer and applied it to Ontario, Canada. The purpose was to identify environmental carcinogens with the greatest impact on cancer burden to support evidence-based decision making. We conducted a probabilistic assessment of the environmental burden of cancer in Ontario. We selected 23 carcinogens that we defined as "environmental" (e.g., pollutants) and were relevant to the province, based on select classifications provided by the International Agency for Research on Cancer. We evaluated population exposure to the carcinogens through inhalation of indoor/outdoor air; ingestion of food, water, and dust; and exposure to radiation. We obtained or calculated concentration-response functions relating carcinogen exposure and the risk of developing cancer. Using both human health risk assessment and population attributable fraction models in a Monte Carlo simulation, we estimated the annual cancer cases associated with each environmental carcinogen, reporting the simulation summary (e.g., mean and percentiles). We estimated between 3540 and 6510 annual cancer cases attributable to exposure to 23 environmental carcinogens in Ontario. Three carcinogens were responsible for over 90% of the environmental burden of cancer: solar ultraviolet (UV) radiation, radon in homes, and fine particulate matter (PM We found the environmental burden of cancer in Ontario to fall between previously estimated burdens of alcohol and tobacco use. These results allow for a comparative assessment across carcinogens and offer insights into strategies to reduce the environmental burden of cancer. Our analysis could be adopted by other jurisdictions and repeated in the future for Ontario to track progress in reducing cancer burden, assess newly classified environmental carcinogens, and identify top burden contributors.

Sections du résumé

BACKGROUND BACKGROUND
Quantifying the potential cancer cases associated with environmental carcinogen exposure can help inform efforts to improve population health. This study developed an approach to estimate the environmental burden of cancer and applied it to Ontario, Canada. The purpose was to identify environmental carcinogens with the greatest impact on cancer burden to support evidence-based decision making.
METHODS METHODS
We conducted a probabilistic assessment of the environmental burden of cancer in Ontario. We selected 23 carcinogens that we defined as "environmental" (e.g., pollutants) and were relevant to the province, based on select classifications provided by the International Agency for Research on Cancer. We evaluated population exposure to the carcinogens through inhalation of indoor/outdoor air; ingestion of food, water, and dust; and exposure to radiation. We obtained or calculated concentration-response functions relating carcinogen exposure and the risk of developing cancer. Using both human health risk assessment and population attributable fraction models in a Monte Carlo simulation, we estimated the annual cancer cases associated with each environmental carcinogen, reporting the simulation summary (e.g., mean and percentiles).
RESULTS RESULTS
We estimated between 3540 and 6510 annual cancer cases attributable to exposure to 23 environmental carcinogens in Ontario. Three carcinogens were responsible for over 90% of the environmental burden of cancer: solar ultraviolet (UV) radiation, radon in homes, and fine particulate matter (PM
CONCLUSIONS CONCLUSIONS
We found the environmental burden of cancer in Ontario to fall between previously estimated burdens of alcohol and tobacco use. These results allow for a comparative assessment across carcinogens and offer insights into strategies to reduce the environmental burden of cancer. Our analysis could be adopted by other jurisdictions and repeated in the future for Ontario to track progress in reducing cancer burden, assess newly classified environmental carcinogens, and identify top burden contributors.

Identifiants

pubmed: 32590953
doi: 10.1186/s12889-020-08771-w
pii: 10.1186/s12889-020-08771-w
pmc: PMC7320572
doi:

Substances chimiques

Carcinogens 0
Carcinogens, Environmental 0
Particulate Matter 0
Asbestos 1332-21-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1017

Références

Occup Environ Med. 2000 Jan;57(1):10-8
pubmed: 10711264
Am J Prev Med. 2008 Feb;34(2):94-101
pubmed: 18201638
JAMA. 2002 Mar 6;287(9):1132-41
pubmed: 11879110
Aust N Z J Public Health. 2015 Oct;39(5):471-6
pubmed: 26437734
CMAJ Open. 2017 Jun 28;5(2):E524-E528
pubmed: 28659352
Environ Res. 2000 Mar;82(3):194-206
pubmed: 10702327
Environ Res. 2008 Feb;106(2):240-9
pubmed: 17904543
Risk Anal. 1994 Feb;14(1):53-73
pubmed: 8146404
Br J Cancer. 2011 Dec 6;105 Suppl 2:S57-65
pubmed: 22158322
Aust N Z J Public Health. 2015 Oct;39(5):403-7
pubmed: 26437722
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31(5):872-88
pubmed: 24471940
Lancet. 2017 Sep 16;390(10100):1345-1422
pubmed: 28919119
Annu Rev Public Health. 2013;34:97-117
pubmed: 23514316
CMAJ Open. 2017 Jul 7;5(3):E540-E545
pubmed: 28687643
Int J Cancer. 2018 Feb 15;142(4):691-701
pubmed: 28983918
Br J Cancer. 2018 Apr;118(8):1130-1141
pubmed: 29567982
CMAJ Open. 2017 Jun 28;5(2):E529-E534
pubmed: 28663187
Health Promot Chronic Dis Prev Can. 2015 Spring;35 Suppl 1:2-186
pubmed: 26011811
Am J Prev Med. 2016 Jul;51(1):1-11
pubmed: 26810358
CA Cancer J Clin. 2018 Jan;68(1):31-54
pubmed: 29160902
Environ Health Perspect. 2014 Sep;122(9):906-11
pubmed: 24911630
J Natl Cancer Inst. 1981 Jun;66(6):1191-308
pubmed: 7017215
Am J Prev Med. 2015 Jul;49(1):20-8
pubmed: 25794474
Cancer Causes Control. 2013 Nov;24(11):2013-20
pubmed: 23982909
Environ Health Perspect. 2014 May;122(5):439-46
pubmed: 24584099
J Clin Endocrinol Metab. 2015 Apr;100(4):1241-4
pubmed: 25844765
Environ Health. 2013 Feb 12;12:15
pubmed: 23398723
Br J Cancer. 2011 Dec 6;105 Suppl 2:S6-S13
pubmed: 22158323
Br J Cancer. 2011 Dec 6;105 Suppl 2:S77-81
pubmed: 22158327
Melanoma Res. 1993 Dec;3(6):395-401
pubmed: 8161879

Auteurs

Susan Lavinia Greco (SL)

Public Health Ontario, Toronto, Ontario, Canada. sue.greco@utoronto.ca.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. sue.greco@utoronto.ca.

Elaina MacIntyre (E)

Public Health Ontario, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Stephanie Young (S)

Cancer Care Ontario, Toronto, Ontario, Canada.

Hunter Warden (H)

Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Ontario, Canada.

Christopher Drudge (C)

Public Health Ontario, Toronto, Ontario, Canada.

JinHee Kim (J)

Public Health Ontario, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Elisa Candido (E)

Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.

Paul Demers (P)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Ontario, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Ray Copes (R)

Public Health Ontario, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH